HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.

Abstract
The influence of in vitro application of the cytostatic agents titanocene dichloride (TDC), vanadocene dichloride (VDC), and cis-diamminedichloroplatinum(II) (DDP) on the cytokinetic behavior of EAT cells was investigated. All three substances induced similar cytokinetic phenomena that are characterized, on the one hand, by an accumulation of cells in the late S phase and in the G2 phase during exposure periods of 8 to 20 h. On the other hand, some cells were apparently arrested at the end of the G1 phase and, after removal of the cytostatic agents, moved through the following S, G2, and M phases as synchronized cell populations. In view of this unusual cytokinetic pattern of multiple effects, it is argued that the striking similarities in cytokinetic behavior after treatment with the three different cytostatic substances indicate analogies in their molecular mechanisms of action. The different alteration patterns observed after in vivo application of the drugs are obviously due to additional processes occurring only in vivo.
AuthorsP Köpf-Maier, W Wagner, E Liss
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 106 Issue 1 Pg. 44-52 ( 1983) ISSN: 0171-5216 [Print] Germany
PMID6684118 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Vanadium Compounds
  • Vanadium
  • vanadocene dichloride
  • Titanium
  • titanocene dichloride
  • Cisplatin
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Carcinoma, Ehrlich Tumor (pathology)
  • Cisplatin (pharmacology)
  • In Vitro Techniques
  • Interphase (drug effects)
  • Mice
  • Organometallic Compounds (pharmacology)
  • Titanium (pharmacology)
  • Vanadium (pharmacology)
  • Vanadium Compounds

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: